Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Maltol in LVAD Patients with Iron Deficiency
NCT03774615Phase 4Terminated
- Sponsor
- Hannover Medical School
- Start
- Mar 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferric maltol in iron deficiency anemia (IDA), sponsored by Hannover Medical School. Primary endpoint: Adverse Events and Serious Adverse Events at 12 weeks. Started Mar 2019; status: terminated.
02
Drugs
ferric maltol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03774615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03774615.